.avif)
Legend Biotech Email Format
Biotechnology Research
・
1,001-2,500 employees
・
Somerset, NJ, USA
Legend Biotech is a global commercial-stage biotechnology company developing and manufacturing novel cell therapies for patients worldwide from facilities in the United States, China, and Belgium.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@legendbiotech.com
Company Overview
Industry
Biotechnology Research
Founded
2014
Headquarters
Somerset, NJ, USA
Revenue
$500M-$1B
FUNDING Stage
Public
Website
Key Executives
Ying Huang (CHIEF EXECUTIVE OFFICER), Carlos Santos (Chief Financial Officer), Dadong Li (Head of Global Information Technology)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Legend Biotech?
Legend Biotech uses the first.last format on legendbiotech.com, so Jane Smith would be jane.smith@legendbiotech.com.
What is CARVYKTI, and how does Legend Biotech develop it?
CARVYKTI (ciltacabtagene autoleucel) is Legend Biotech's FDA-approved CAR-T cell therapy for relapsed or refractory multiple myeloma. It targets the BCMA protein and is co-developed and commercialized with Janssen Biotech, Inc. under a global collaboration agreement.
Where does Legend Biotech have manufacturing facilities?
Legend Biotech operates manufacturing facilities across multiple continents, including sites in Somerset and Piscataway, New Jersey, Nanjing, China, and Ghent, Belgium, with additional operations in Dublin, Ireland.
How can I find and verify a Legend Biotech employee's contact information?
Since Legend Biotech follows the first.last@legendbiotech.com format, you can build most addresses directly. Tools like Clay can help you verify those addresses or enrich a prospect list with confirmed Legend Biotech contacts before outreach.
Beyond CAR-T, what other cell therapy platforms is Legend Biotech developing in its pipeline?
Legend Biotech is advancing a pipeline that spans CAR-T, CAR-NK, CAR-gamma-delta T, and non-gene-editing CAR technologies, positioning the company across multiple approaches to cell therapy for cancer treatment.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating